This Article  • Full text  • PDF  • Correction  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Oncology  • Head & Neck Cancer  • Neoplasms of Head & Neck  • Prognosis/ Outcomes  • Alert me on articles by topic  Social Bookmarking   What's this?

Results From Intergroup Study ECOG 4393/RTOG 9614

Wayne M. Koch, MD; John A. Ridge, MD, PhD; Arlene Forastiere, MD; Judith Manola, MS

Arch Otolaryngol Head Neck Surg. 2009;135(9):851-858.

Objectives  To compare the results of clinical and pathological staging for a large cohort of patients with head and neck squamous cell carcinoma (HNSCC) and to examine patterns and ramifications of the disparity between staging methods.

Design  Prospective inception cohort (median follow-up, 7 years).

Setting  Multi-institutional cooperative group study (Eastern Cooperative Oncology Group 4393/Radiation Therapy Oncology Group 9614) involving 17 academic medical centers.

Patients  A total of 560 patients with new-onset or recurrent HNSCC enrolled during a 7-year period.

Interventions  Surgical resection with curative intent with or without adjuvant or previous radiotherapy or chemotherapy.

Main Outcome Measures  Clinical staging and pathological staging and the component TN tumor categories were compared with overall and disease-specific survival. Association of survival with staging was derived by means of the proportional hazards model.

Results  Of the 501 cases in which both clinical and pathological staging was available, a disparity was found between at least 1 component tumor category assigned by the 2 methods in almost 50% of cases. Both methods showed a strong association of stage with overall survival for the cohort at large. However, pathological nodal category was a superior predictor (P < .001 vs P = .005), whereas there was an advantage to pathological tumor category in predicting disease-specific survival (P = .01).

Conclusions  Both staging methods are useful in predicting survival, whereas information gained at neck dissection regarding nodal metastases provides some refinement in prognostic results. These findings demonstrate the need for enhanced methods of tumor assessment and apparent benefit of data gathered at neck dissection for accurate disease assessment and stratification.

Author Affiliations: Department of Otolaryngology–Head and Neck Surgery, The Johns Hopkins University, Baltimore, Maryland (Drs Koch and Forastiere); Head and Neck Surgery, Fox Chase Cancer Center, Philadelphia, Pennsylvania (Dr Ridge); and Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts (Ms Manola).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?